Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate
2005-11-08
2005-11-08
Andres, Janet (Department: 1647)
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
C424S085400, C424S093100, C424S093210, C424S093600, C424S093710, C435S070100, C435S070300, C435S325000, C530S351000
Reexamination Certificate
active
06962695
ABSTRACT:
A process for the production of α-interferon comprising the steps: i) inducing of human leukocytes by means of a virus; ii) treating the leukocytes with an enhancing agent selected from: a) Xanthine, pyrimidinol and pyrimidinone or derivatives of anyone thereof, such as theophylline, 2-amino-5-bromo-6-methyl-4 pyriminidol or thymine; b) an organic solvent selected from the group consisting of non-aromatic ketones, aliphatic or cyclic amides, alkylated aliphatic or cyclic urea derivatives and aliphatic or cyclic sulfoxides, such as N-methyl-2-pyrrolidinone, acetone, 2-butanone, 1,3-dimethyl-2-imidazolidinone, dimethylsulfoxide, 4-methyl-2-pentanone-N-ethyl-2-pyrrolidinone, 2-pyrrolidinone, tetramethylene sulfoxide or N,N-dimethylacetamide; or a combination of the compounds from a) with an organic solvent from b).
REFERENCES:
patent: 3932617 (1976-01-01), Nichol, Jr. et al.
patent: 4027021 (1977-05-01), Underwood
patent: 4266024 (1981-05-01), Swetly et al.
patent: 4780413 (1988-10-01), Johnston
patent: 0 000 520 (1979-02-01), None
patent: 0 048 283 (1982-03-01), None
patent: 0 097 353 (1984-01-01), None
Fan et al., “Increased Efficacy of Human Natural Interferon α (IFN-αn3) Versus Human Recombinant IFN-α2 for Inhibition of HIV-1 Replication in Primary Human Monocytes”, AIDS Research and Human Retroviruses, 1993, 1115-1123, 9(11), Mary Ann Liebert, Inc., Publishers, Larchmont, NY, USA.
Heim et al., “Cultured Human Myocardial Fibroblasts of Pediatric Origin: Natural Human Interferon-α is More Effective than Recombinant Interferon-α 2a in Carrier-state Coxsackievirus B3 Replication”, J. Mol. Cell Cardiol, 1995, 2119-2208, 27, Academic Press Limited, Burlington, MA, USA.
Weissmann et al., “Structure and Expression of Human IFN-α Genes”, Phil. Trans. R. Soc. Lond., 1982, 7-82, 299, The Royal Society, London, United Kingdom.
Antonelli et al., “Interferon Antibodies in Patients with Infectious Diseases”, Biotherapy, 1997, 7-14, 10, Kluwer Academic Publishers, The Netherlands.
Öberg et al., “The Incidence and Clinical Significance of Antibodies to Interferon-α in Patients with Solid Tumors”, Biotherapy, 1997, 1-5, 10, Kluwer Academic Publishers, The Netherlands.
Goren et al., “Human Monocytes and Lymphocytes Produce Different Mixtures of α-Interferon Subtypes”, 1986, 323-329, 6, Mary Ann Liebert, Inc., Publishers, Larchmont, NY, USA.
Gabrilovac et al., “Leu-enkephalin Enhances Interferon Secretion in Mice”, Res Exp Med, 1996, 137-144, 196, Experimental Medicine, Springer-Verlag, The Netherlands.
Mezentseva et al., The Influence of Ridostin and Cycloferonum on IFN Production in Cells of MIce with T- and B-Immunodeficites, Gamaleya Institute of Epidemiology and Microbiology, Moscow, Russia.
Galabov et al., “Dipyridamole Induces Interferon in Man”, Biomedicine & Pharmacotherapy, 1984, 412-413, 38, Elsevier Science, New York, NY, USA.
Stringfellow et al., “Interferon induction by 5-Halo-6-Phenyl Pyrimidinones”, Journal of Interferon Research, 1980, 1-14, 1(1), Mary Ann Liebert, Inc., Publishers, Larchmont, NY, USA.
Chelbi-Alix et al., “Ethanol Induces 2',5'-Oligoadenylate Synthetase and Antiviral Activities through Interferon-β Production”, The Journal of Biological Chemistry, 1992, 1741-1745, 267(3), The American Society for Biochemistry and Molecular Biology, Inc., USA.
Lin et al., Role of Calmodulin/Protein Kinase C in Interferon Production by Poly(rl)—Poly(rC) in Primed Human Cell Cultures, Journal of Interferon Research, 1990, 375-378, 10, Mary Ann Liebert, Inc., Publishers, Larchmont, NY, USA.
Zahorska et al., “Influence of Theophylline on Interferon Production and cAMP Level in Lpa Cells”, Archivum Immunologiae et Therapiae Experimentalis, 1995, 43-46, 43, Polish Academy of Sciences, Wroclaw, Poland.
Sandberg et al., “A Distinct Population of Nonphagocytic and Low Level CD4+Null Lymphocytes Produce IFN-α after Stimulation by Herpes Simplex Virus-Infected Cells”, The Journal of Immunology, 1990, 1015-1020, 145, The American Association of Immunologist, USA.
Cantell et al., “Production of Interferon in Human Leukocytes from Normal Donors with the Use of Sendai Virus”, Methods in Enzymology, 1981, 29-38, 78, Academic Press, Inc., Burlington, MA, USA.
Morser et al., “Low Temperature Treatment of Namalwa Cells Causes Superproduction of Interferon”, J. Gen. Virol., 1981, 163-174, 56, Society for General Microbiology, Reading, United Kingdom.
E. Slattery et al. “Mouse Interferon: Production by Ehrlich Ascites Tumour Cells Infected with Newcastle Disease Virus and its Enhancement by Theophylline”J. Gen. Virol(1980) 49: 91-96.
Annekatrin Stecher et al., “Interferon-α Yields From Sendai Virus-Induced Human Leukocyte Cultures Are Enhanced by Lowering the Incubation Temperature”, J. gen. Virol, (1984), pp. 635 to 638, vol. 65, Printed in Great Britain.
Haye et al., ATCC Cell Lines and Hybridomas, 8thEdition, 1994, cover page and p. 45, The American Type Culture Collection, Rockville, MD.
Namalwa, DSMZ No. ACC 24, DSMZ-Deutsche Sammlung von Milroorganismen und Zellkulturen GmbH, Germany.
Sell et al, Immunology, Immunopathology & Immunity, 5thEdition, cover page, Figure 2-8, pp. 42 and 827, Appleton & Lange, Stamford, CT.
Lackie et al., The Dictionary of Cell Biology, 2ndEdition, cover page, pp. 364 and 292, Academic Press, Boston, MA.
Freshney, Culture of Animal Cells, A Manual of Basic Technique, 4thEdition, pp. 5-6, 16-17, 259-260, 269 and 273, A John Wiley & Sons, Inc., New York, NY.
Andres Janet
Bionative AB
Burns Doane , Swecker, Mathis LLP
Seharaseyon Jegatheesan
LandOfFree
Modification of interferon alpha production does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modification of interferon alpha production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modification of interferon alpha production will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3506529